Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
Lancet Neurol
; 16(1): 43-54, 2017 Jan.
Article
em En
| MEDLINE
| ID: mdl-27889312
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Carbamazepina
/
Resultado do Tratamento
/
Epilepsia
/
Acetamidas
/
Anticonvulsivantes
Tipo de estudo:
Clinical_trials
/
Diagnostic_studies
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Lancet Neurol
Assunto da revista:
NEUROLOGIA
Ano de publicação:
2017
Tipo de documento:
Article